急性呼吸器不全症候群の患者における病院での治療結果へのエヴァーピングの影響
Danny V Tran1, Nicholas W Sheets2, Jocelyn Limas3
1Internal Medicine, HCA Florida Trinity Hospital, Trinity, USA.
Cureus
|September 2, 2025
まとめ
急性呼吸困難症候群 (ARDS) の患者では,機械呼吸器の必要性を減らせる可能性があります. しかし,この研究はサンプルサイズが小さいため,電子タバコとARDSに関する結果の力を制限しました.
科学分野:
- 肺科
- クリティカル ケア 医療
- 流行病学
背景:
- EVALIのような急性肺損傷の 症例が増えています
- 急性呼吸器障害症候群 (ARDS) に及ぼす影響に関するデータは限られている.
研究 の 目的:
- ARDSと診断された患者の病院でのアウトカムに対するエヴァープの効果を調査する.
主な方法:
- ARDS患者によるレトロスペクティブチャートレビュー (2016年−2022年)
- 分析には人口統計,併発症,機械呼吸器,ICU/入院期間,死亡率が含まれていた.
- 統計的方法には,キ平方,ロジスティック回帰,負二項回帰が含まれ,混同因子を制御する.
主要な成果:
- 機械的な換気が必要になる確率は著しく低下した (OR: 0. 377, p=0. 045)
- 非侵襲的な呼吸器の使用,入院/ICUの滞在時間,または死亡率において有意な差異は認められなかった.
- 人口統計と併発症は,vapingとnon-vapingのグループ間で有意な違いを示さなかった.
結論:
- ARDS患者における機械呼吸器の必要性の低下と関連している可能性があります.
- この研究のサンプルサイズが小さいので (42人のバイパー) 結論の概括性や効果は限られている.
- ARDSとの複雑な関係を理解するためにさらなる研究が必要です.
さらに関連する動画
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
6.7K
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.5K
関連する概念動画
Acute Respiratory Failure-V
203
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
203
Acute Respiratory Failure-II
357
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
357
Acute Respiratory Failure-I
320
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
320
Acute Respiratory Failure-IV
227
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
227
Acute Respiratory Failure-III
316
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
316
Stimulants
311
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
311
